Bayer
Works in Cardiovascular · Dermatology · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Renal & urogenital · Respiratory · Women's health
Bayer is a clinical trial sponsor. It has 87 active clinical trials with 609,635 planned participants, across 16 therapeutic areas. Since 2021 it has completed 421 trials and stopped 40 early.
Trial track record · since 2021
Pipeline · 87 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
50 approved drug applications with a product on the market.
Questions about Bayer
Bayer is lead sponsor of 87 active clinical trials on ClinicalTrials.gov, with 609,635 planned participants, in Cardiovascular, Dermatology, ENT, Genetic & rare and other areas. Since 2021 it has completed 421 trials and stopped 40 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Bayer; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
Approve Suite is not affiliated with Bayer. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.